Episode Description
Dr. Marco Ruella joins Dr. Monty Pal to discuss landmark 10-year follow-up data on tisa-cel CAR T-cell therapy for B-cell lymphomas, as well as emerging advances in dual-targeted CARs and their shift into earlier lines of treatment.



























